CytoSorbents Corp. (CTSO)
6.01
+0.66
(+12.34%)
USD |
NASDAQ |
Oct 22, 16:00
5.71
-0.30
(-4.99%)
After-Hours: 05:38
CytoSorbents Profit Margin (Quarterly) : -45.85% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -45.85% |
| March 31, 2026 | -57.86% |
| December 31, 2025 | -59.53% |
| September 30, 2025 | -33.42% |
| June 30, 2025 | 20.25% |
| March 31, 2025 | -16.94% |
| December 31, 2024 | -120.9% |
| September 30, 2024 | -32.14% |
| June 30, 2024 | -48.56% |
| March 31, 2024 | -67.73% |
| December 31, 2023 | -83.49% |
| September 30, 2023 | -104.3% |
| June 30, 2023 | -65.31% |
| March 31, 2023 | -77.53% |
| December 31, 2022 | -8.16% |
| September 30, 2022 | -150.4% |
| June 30, 2022 | -128.1% |
| March 31, 2022 | -103.2% |
| December 31, 2021 | -86.32% |
| September 30, 2021 | -65.64% |
| June 30, 2021 | -38.90% |
| March 31, 2021 | -39.32% |
| December 31, 2020 | -5.67% |
| September 30, 2020 | -7.96% |
| June 30, 2020 | -29.27% |
| Date | Value |
|---|---|
| March 31, 2020 | -39.65% |
| December 31, 2019 | -53.15% |
| September 30, 2019 | -113.0% |
| June 30, 2019 | -56.92% |
| March 31, 2019 | -94.07% |
| December 31, 2018 | -88.86% |
| September 30, 2018 | -52.32% |
| June 30, 2018 | -101.1% |
| March 31, 2018 | -60.55% |
| December 31, 2017 | -67.73% |
| September 30, 2017 | -53.72% |
| June 30, 2017 | -48.64% |
| March 31, 2017 | -48.98% |
| December 31, 2016 | -159.1% |
| September 30, 2016 | -90.73% |
| June 30, 2016 | -135.2% |
| March 31, 2016 | -101.4% |
| December 31, 2015 | -113.7% |
| September 30, 2015 | -211.9% |
| June 30, 2015 | |
| March 31, 2015 | -652.3% |
| December 31, 2014 | -571.7% |
| September 30, 2014 | -128.9% |
| June 30, 2014 | -180.9% |
| March 31, 2014 | -91.80% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Abbott Laboratories | 7.07% |
| AngioDynamics, Inc. | -8.77% |
| Alphatec Holdings, Inc. | -12.07% |
| AtriCure, Inc. | 5.83% |
| Baxter International, Inc. | 4.56% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -325.8% |
| Return on Assets | -41.41% |
| Return on Invested Capital | -53.06% |
| Gross Profit Margin (Quarterly) | 73.18% |
| Operating Margin (Quarterly) | -23.92% |
| Return on Net Operating Assets | -53.89% |